Spire Healthcare Group (LON:SPI) Stock Price Up 16.4% - Time to Buy?

Key Points

• Spire Healthcare Group's shares rose by 16.4% on Friday, reaching a last traded price of GBX 252 ($3.42), with trading volume surging to approximately 39.5 million shares.
• Analysts have a consensus rating of "Buy" for Spire Healthcare Group, with an average price target of GBX 294.33, despite some mixed revisions in price targets from firms like Berenberg Bank and JPMorgan Chase & Co..
• For the recent quarter, Spire Healthcare reported earnings of GBX 4.10 per share, with an expected 15.66 earnings per share forecast for the current year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares rose 16.4% during mid-day trading on Friday . The stock traded as high as GBX 256.50 ($3.46) and last traded at GBX 252 ($3.40). Approximately 39,487,281 shares changed hands during mid-day trading, an increase of 2,319% from the average daily volume of 1,632,481 shares. The stock had previously closed at GBX 216.50 ($2.92).

Wall Street Analysts Forecast Growth

SPI has been the topic of several recent analyst reports. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 280 price target on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. lowered their target price on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a research note on Tuesday, August 5th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of "Buy" and a consensus price target of GBX 294.33.

Spire Healthcare Group Stock Up 14.1%

The firm's 50-day moving average price is GBX 218.75 and its 200 day moving average price is GBX 203.41. The firm has a market cap of £993.86 million, a P/E ratio of 5,369.57, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, research analysts expect that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.